PRMT5 and cancer: Overexpression or dysregulation of PRMT5 has been observed in various cancer types, including breast78,79, lung80,81, ovarian82, prostate83, colorectal84, gastric85,86, liver87,88, pancreatic89,90, head and neck91, bladder92, lymphoma93,94, melanoma95, and glioma96.